
Experimental Alzheimer’s drug slows disease, researchers say
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Graham Richardson speaks with a scientist at the Alzheimer Society of Canada on an experimental Alzheimer's drug which slowed cognitive decline overall in a trial, but with major side effects for some.
On today’s show:
- A conversation with Dr. Joshua Armstrong, research scientist at the Alzheimer Society of Canada.
- Michael Findlay, former Canadian Senior Men’s National Team head coach and assistant coach, on Canada’s run at the World Cup.
- Overhyped v. Underplayed Scott Reid, CTV News political commentator, and former communications director for Prime Minister Paul Martin.
- Jasbir Romana, a radio host in Vancouver, British Columbia. He was stranded due to the snowstorm this week and had to seek refuge in a stranger’s home.
- A global 4-day week pilot was a huge success, organizers say. We speak with Juliet Schor, professor of sociology at Boston College and the trial’s lead researcher.
- When does the holiday season officially start for you? We take your calls.
- Riskin It All with Dan Riskin, CTV science and technology specialist.
Ce que les auditeurs disent de Experimental Alzheimer’s drug slows disease, researchers say
Moyenne des évaluations de clientsÉvaluations – Cliquez sur les onglets pour changer la source des évaluations.
Il n'y a pas encore de critiques pour ce titre.